Welcome back to The Trip Report Podcast, a production of Beckley Waves, a Psychedelic Venture Studio.

This week, I am speaking with Greg Kubin, co-host of the Business Trip Podcast and co-founder and partner at PsyMed Ventures, a fund investing in frontier mental health technologies and treatments.

Greg and I chat pretty regularly, sometimes weekly, about the state of play in psychedelics, neurotech, investing, consciousness, and a rapidly changing world.

As an early-stage investor in frontier mental health and wellness technologies, Greg has a unique lens into what future approaches and landscapes might look like.

A recent focus in my writing has been the ‘emergent paradigms’ afoot that are nearing—or achieved—tipping points in their acceptance and application; in this conversation, Greg and I discuss a handful of these topics, including:

* The Gut-Brain-Axis and the innovations afoot in diagnostics and precision pre & probiotics

* Metabolic Health, its impact on mental health, and tools like the ketogenic diet

* Neurotechnology and Brain-Computer Interface for diagnostics and therapeutics

We also discuss:

* The origin story of PsyMed Ventures and the Business Trip Podcast

* The pharmaceutical industrial complex

* The relationship between academic research and commercialization and the archetype of the “Entrepreneurial Scientist.”

As well as many colorful tangents, digressions, and detours.

And now, I bring you my conversation with Greg Kubin.

Listen to the episode on Substack, Spotify, Google or Apple.

Credits:

* Hosted by Zach Haigney 

* Produced by Zach Haigney, Erin Greenhouse, and Katelin Jabbari

* Find us at thetripreport.com

* Follow us on Instagram, Twitter, LinkedIn and YouTube

* Theme music by MANCHO Sounds, Mixed and Mastered by Rollin Weary

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.thetripreport.com